IRIS
LOMBARDI, GAETANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.599
AS - Asia 4.876
EU - Europa 4.649
SA - Sud America 286
AF - Africa 139
Continente sconosciuto - Info sul continente non disponibili 16
OC - Oceania 6
Totale 18.571
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.445
SG - Singapore 2.303
CN - Cina 1.387
HK - Hong Kong 938
DE - Germania 710
IT - Italia 707
FI - Finlandia 644
SE - Svezia 537
IE - Irlanda 485
RU - Federazione Russa 477
NL - Olanda 473
UA - Ucraina 296
BR - Brasile 241
GB - Regno Unito 158
CA - Canada 133
CI - Costa d'Avorio 118
TR - Turchia 65
IN - India 60
FR - Francia 48
BE - Belgio 27
IR - Iran 24
VN - Vietnam 17
EU - Europa 16
MX - Messico 16
CZ - Repubblica Ceca 14
IQ - Iraq 14
CO - Colombia 13
ES - Italia 12
AR - Argentina 11
AT - Austria 10
JP - Giappone 10
BD - Bangladesh 9
CH - Svizzera 7
LT - Lituania 7
CL - Cile 6
EG - Egitto 6
PL - Polonia 6
RO - Romania 6
DK - Danimarca 5
DZ - Algeria 5
EC - Ecuador 5
KR - Corea 5
MY - Malesia 5
TH - Thailandia 5
AU - Australia 4
NO - Norvegia 4
PE - Perù 4
UZ - Uzbekistan 4
ZA - Sudafrica 4
AE - Emirati Arabi Uniti 3
GE - Georgia 3
GR - Grecia 3
HR - Croazia 3
HU - Ungheria 3
LV - Lettonia 3
PK - Pakistan 3
BO - Bolivia 2
IL - Israele 2
LK - Sri Lanka 2
MA - Marocco 2
NG - Nigeria 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PA - Panama 2
PH - Filippine 2
PS - Palestinian Territory 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
TW - Taiwan 2
VE - Venezuela 2
AM - Armenia 1
AZ - Azerbaigian 1
GY - Guiana 1
HN - Honduras 1
ID - Indonesia 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
PR - Porto Rico 1
UY - Uruguay 1
Totale 18.571
Salva come PNG Salva come JPEG
Città #
Chandler 1.523
Singapore 1.285
Hong Kong 937
Jacksonville 664
Millbury 597
Santa Clara 591
Princeton 510
Amsterdam 436
Nanjing 421
Wilmington 331
Ashburn 274
Naples 233
Beijing 198
Woodbridge 156
Nanchang 149
Boston 146
Helsinki 139
Ottawa 108
Norwalk 94
Shenyang 77
Seattle 72
Ann Arbor 63
Hebei 62
Napoli 61
Jiaxing 60
Falkenstein 59
Falls Church 56
Tianjin 53
Boardman 51
Houston 50
Kunming 49
Changsha 42
Kronberg 39
Moscow 39
Munich 35
Redwood City 34
Indiana 29
The Dalles 29
Dublin 27
Washington 27
San Mateo 24
Los Angeles 22
Pune 21
Shanghai 21
Lanzhou 20
Redmond 20
São Paulo 20
Toronto 20
Frankfurt am Main 19
Ardabil 18
Augusta 18
Rome 18
Jinan 17
Dallas 16
Des Moines 16
Dong Ket 16
San Francisco 16
Milan 15
New York 14
Guangzhou 13
Istanbul 13
Yellow Springs 13
Dearborn 12
Hangzhou 12
Tappahannock 12
Brno 11
Changchun 11
London 11
Zhengzhou 11
Brussels 10
Leawood 10
Ningbo 10
Nuremberg 10
Council Bluffs 9
Duncan 8
Rio de Janeiro 8
Sandston 8
Orange 7
Baghdad 6
Belo Horizonte 6
Casoria 6
Courcelles 6
Paris 6
Brasília 5
Casalbore 5
Fremont 5
Mexico City 5
Monfalcone 5
Simi Valley 5
Taizhou 5
Vienna 5
Aracaju 4
Bangalore 4
Chengdu 4
Clifton 4
Dhaka 4
Monmouth Junction 4
Oslo 4
Prineville 4
San Prisco 4
Totale 10.462
Salva come PNG Salva come JPEG
Nome #
Systemic complications of acromegaly: epidemiology, pathogenesis, and management 408
Circulating insulin-like growth factor-I levels are correlated with the atherosclerotic profile in healthy subjects independently of age 93
A protein family immunorelated to a sperm-binding protein and its regulation in human semen. 81
Short-term effects of growth hormone (GH) treatment or deprivation on cardiovascular risk parameters and intima-media thickness at carotid arteries in patients with severe GH deficiency 79
Lack of electrocardiographic changes in women with polycystic ovary syndrome. 75
Antipituitary antibodies in idiopathic hyperprolactinemic patients 75
Role of dehydroepiandrosterone sulfate levels on body composition after laparoscopic adjustable gastric banding in pre-menopausal morbidly obese women. 75
Effect of gender and gonadal status on the long-term response to somatostatin analogue treatment in acromegaly 73
Effects of sex steroids on bone in women with subclinical or overt endogenous hypercortisolism 73
GH INSUFFICIENCY IN OBESE PATIENTS. 72
Correlation between Seminal Carnitine and Functional Spermatozoal Characteristics in Men with Semen Dysfunction of Various Origins 71
Thyroid function and morphology after a successful kidney transplantation. 69
Efficacy and safety of radiofrequency thermal ablation in the treatment of thyroid nodules with pressure symptoms in elderly patients. 69
Subtle alterations of cardiac performance in children with growth hormone deficiency: results of a two-year prospective, case-control study. 69
Weekly clodronate treatment prevents bone loss and vertebral fractures in womenwith subclinical Cushing's syndrome. 69
Combined therapy of somatostatin analogues and dopamine agonists in the treatment of pituitary tumours 68
Sulfur amino acids in Cushing's disease: insight in homocysteine and taurine levels in patients with active and cured disease 68
CORRELATION BETWEEN SEMINAL CARNITINE AND FUNCTIONAL CHARACTERISTICS IN MEN WITH SEMEN DYSFUNCTION OF VARIOUS ORIGINS. 67
Increased prevalence of thyroid autoimmunity and hypothyroidism in patients with glycogen storage disease type I 65
A retrospective analysis on biochemical parameters, cardiovascular risk and cardiomyopathy in elderly acromegalic patients 65
Predictors of tumor shrinkage after primary therapy with somatostatin analogs in acromegaly: a prospective study in 99 patients 65
Cardiopulmonary impairment in young women with polycystic ovary syndrome 65
Prolactin and prostate hypertrophy: a pilot observational, prospective, case-control study in men with prolactinoma 64
Endocrine dysfunction in patients with Fabry disease 64
Efficacy of 12-month treatment with the GH receptor antagonist pegvisomant in patients with acromegaly resistant to long-term, high-dose somatostatin analog treatment: effect on IGF-I levels, tumor mass, hypertension and glucose tolerance 64
The treatment with growth hormone receptor antagonist in acromegaly: effect on vascular structure and function in patients resistant to somatostatin analogues. 64
Subclinical hyperthyroidism: clinical features and treatment options. 63
Epidemiology, diagnosis, and treatment of male hypogonadotropic hypogonadism. 63
Homocysteine levels and C677T polymorphism of methylenetetrahydrofolate reductase in women with polycystic ovary syndrome 62
Orbital scintigraphy with [111In-diethylenetriamine pentaacetic acid-D-phe1]-octreotide predicts the clinical response to corticosteroid therapy in patients with Graves' ophthalmopathy. 62
The association of fasting insulin concentrations and colonic neoplasms in acromegaly: a colonoscopy-based study in 210 patients 61
Effects of short-term treatment with orlistat on growth hormone/insulin-like growth factor-I axis in obese post-menopausal women. 61
Epidemiology of non-gastroenteropancreatic (neuro)endocrine tumours. 60
31. SIX MONTHS OF TREATMENT WITH CABERGOLINE RESTORES SEXUAL POTENCY IN HYPERPROLACTINEMIC MALES. AN OPEN LONGITUDINAL STUDY MONITORING NOCTURNAL PENILE TUMESCENCE. 60
The natural history of partial growth hormone deficiency in adults: a prospective study on the cardiovascular risk and atherosclerosis. 59
Bone demineralization and vertebral fractures in endogenous cortisol excess: role of disease etiology and gonadal status 58
Differences of myocardial systolic deformation and correlates of diastolic function in competitive rowers and young hypertensives: a speckle-tracking echocardiography study. 58
Effects of neridronate treatment in elderly women with osteoporosis 57
L'ESPOSIZIONE AMBIENTALE è UN FATTORE DI RISCHIO MASCHILE? 56
Recombinant thyrotropin-induced orbital uptake of [111In-diethylenetriamine-pentacetic acid-D-Phe1]octreotide in a patient with inactive Graves' ophthalmopathy. 56
Hypertension in acromegaly and in the normal population: prevalence and determinants 56
Advances in the treatment of prolactinomas 56
Overexpression of the phosphoprotein enriched in diabetes gene product (Ped/pea-15) in women with polycystic ovary syndrome. 56
Cushing's syndrome 56
Cabergoline treatment rapidly improves gonadal function in hyperprolactinemic males: a comparison with bromocriptine 56
Identification and preliminary characterization of a sperm-binding protein in normal human semen 55
ANP, AVP, AND PITUITARY-THYROID AXIS IN PATIENTS WITH CONGESTIVE HEART FAILURE AND ACUTE RESPIRATORY FAILURE. 55
SOM230, a new somatostatin analogue, is highly effective in the therapy of growth hormone/prolactin-secreting pituitary adenomas. 55
Age changes the diagnostic accuracy of mean profile and nadir growth hormone levels after oral glucose in postoperative patients with acromegaly. 55
The treatment with cabergoline for 24 month normalizes the quality of seminal fluid in hyperprolactinaemic males. 55
Different degrees of GH deficiency evidenced by GHRH+arginine test and IGF-I levels in adults with pituritary disease 54
Cardiovascular risk factors and common carotid artery caliber and stiffness in patients with Cushing's disease during active disease and 1 year after disease remission 54
Two mutations of BRCA2 gene at exon and splicing site in a woman who underwent oncogenetic counseling 54
Predictive value of pentagastrin test for preoperative differential diagnosis between C-cell hyperplasia and medullary thyroid carcinoma in patients with moderately elevated basal calcitonin levels. 54
Role of IGF-I on PTH effects on bone. 54
Cushing's syndrome: aftermath of the cure. 54
A decrease of calcitonin serum concentrations less than 50 percent 30 minutes after thyroid surgery suggests incomplete C-cell tumor tissue removal. 53
Limitations of Chromogranin A in clinical practice. 53
Pituitary tumors and pregnancy: the interplay between a pathologic condition and a physiologic status. 53
The cut-off limits of the GH response to GH-releasing hormone-arginine test related to body mass index. 52
First-line octreotide-LAR therapy induces tumour shrinkage and controls hormone excess in patients with acromegaly: results from an open, prospective, multicentre trial. 52
Alpha-melanocyte-stimulating hormone is present in the inferior petrosal sinuses in patients with Cushing's disease. 52
Macroprolactinoma shrinkage during cabergoline treatment is greater in naive patients than in patients pretreated with other dopamine agonists: a prospective study in 110 patients 52
Lack of an association between peroxisome proliferator-activated receptor-gamma gene Pro12Ala polymorphism and adiponectin levels in the polycystic ovary syndrome 52
The Mia/Cd-rap gene expression is downregulated by the high-mobility group A proteins in mouse pituitary adenomas. 51
Common carotid intima-media thickness in growth hormone (GH)-deficient adolescents: a prospective study after GH withdrawal and restarting GH replacement. 51
Partial surgical removal of growth hormone-secreting pituitary tumors enhances the response to somatostatin analogs in acromegaly 51
Bone marker and bone density responses to dopamine agonist therapy in hyperprolactinemic males 51
Acromegalic axial arthropathy: a clinical case-control study 51
Acute and chronic effects of human recombinant GH (hrGH) on adrenal steroidogenesis in children affected with isolated GH deficiency (IGHD) 51
A longitudinal study of vasopressin cell antibodies, posterior pituitary function, and magnetic resonance imaging evaluations in subclinical autoimmune central diabetes insipidus 51
A reappraisal of diagnosing GH deficiency in adults: role of gender, age, waist circumference, and body mass index. 51
Effects of initial therapy for five years with somatostatin analogs foracromegaly on growth hormone and insulin-like growth factor-I levels, tumorshrinkage, and cardiovascular disease: a prospective study. 51
Improvement in endothelial structure and function after metformin treatment in young normal-weight women with polycystic ovary syndrome: results of a 6-month study 50
Cardiac effects of GH 50
Correlation of scintigraphic results using 123I-methoxybenzamide with hormone levels and tumor size response to quinagolide in patients with pituitary adenomas 50
An evaluation of patients with hyperprolactinemia: have dynamic tests had their day? 50
Octreotide-LAR vs lanreotide-SR as first-line therapy for acromegaly: A retrospective, comparative, head-to-head study 50
Beneficial effects of a three-month structured exercise training program on cardiopulmonary functional capacity in young women with polycystic ovary syndrome 50
Association of arginine vasopressin-secreting cell, steroid-secreting cell, adrenal and islet cell antibodies in a patient presenting with central diabetes insipidus, empty sella, subclinical adrenocortical failure and impaired glucose tolerance. 50
Prevalence of the metabolic syndrome in moderately-severely obese subjects with and without growth hormone deficiency. 50
Complete disappearance of a GH-secreting pituitary macroadenoma in a patient with acromegaly: effect of treatment with lanreotide Autogel and consequence of treatment withdrawal. 50
Thyroid function in Fabry disease before and after enzyme replacement therapy. 50
Altered glycosylation of pituitary gonadotropins in anorexia nervosa: an alternative explanation for amenorrhea 49
Cardiac structural and functional abnormalities in adult patients with growth hormone deficiency 49
Leuprolide acetate treatment with and without coadministration of tibolone in premenopausal women with menstrual cycle-related irritable bowel syndrome. 49
Clinical and prognostic implications of the genetic diagnosis of hereditary NET syndromes in asymptomatic patients 49
Adjuvant Growth Hormone therapy in severely obese women with Growth Hormone Deficiency after Laparoscopic Adjustable Silicone Gastric Banding. 49
ASSOCIATION OF EARLY CAROTID ATHEROSCLEROSIS WITH HYPERINSULINEMIA AND LOW DHEA(S) IN NORMOTENSIVE SEVERE OBESE WOMEN. 49
Growth hormone excess with onset in adolescence: clinical appearance and long-term treatment outcome 48
Appropriate use of stimulation tests and insulin-like growth factor-I in obesity 48
Corticotropin-releasing hormone administration increases alpha-melanocyte-stimulating hormone levels in the inferior petrosal sinuses in a subset of patients with Cushing's disease 48
Acromegaly and the cardiovascular system 48
PRL secreting adenomas in male patients 48
Dopamine receptor expression and function in clinically nonfunctioning pituitary tumors: comparison with the effectiveness of cabergoline treatment 48
A quick method to detect circulating anti-thyroid hormone autoantibodies. 48
Growth hormone status in morbidly obese subjects and correlation with body composition 47
Bone density and turnover in young adult patients with growth hormone deficiency after 2-year growth hormone replacement according with gender 47
Growth hormone treatment on atherosclerosis: results of a 5-year open, prospective, controlled study in male patients with severe growth hormone deficiency. 47
Metabolic and cardiovascular consequences of polycystic ovary syndrome 47
Totale 6.081
Salva come PNG Salva come JPEG
Categoria #
all - tutte 99.321
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 99.321
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020702 0 0 0 0 0 0 0 0 7 89 180 426
2020/20211.219 22 62 151 72 66 286 85 28 122 66 198 61
2021/20223.273 55 22 18 39 83 331 44 109 507 258 591 1.216
2022/20233.422 572 318 114 292 403 341 18 264 458 444 154 44
2023/20242.044 91 354 322 145 75 153 34 219 17 36 357 241
2024/20255.427 604 790 41 102 315 769 1.350 821 635 0 0 0
Totale 19.009